Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy.
Maruko, Ichiro
Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy. [electronic resource] - American journal of ophthalmology Sep 2013 - 548-556 p. digital
Publication Type: Journal Article
1879-1891
10.1016/j.ajo.2013.03.041 doi
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Choroid--pathology
Choroid Diseases--diagnosis
Coloring Agents
Combined Modality Therapy
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Indocyanine Green
Male
Middle Aged
Ophthalmoscopy
Organ Size
Photochemotherapy
Polyps--diagnosis
Ranibizumab
Recurrence
Retrospective Studies
Tomography, Optical Coherence
Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy. [electronic resource] - American journal of ophthalmology Sep 2013 - 548-556 p. digital
Publication Type: Journal Article
1879-1891
10.1016/j.ajo.2013.03.041 doi
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Choroid--pathology
Choroid Diseases--diagnosis
Coloring Agents
Combined Modality Therapy
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Indocyanine Green
Male
Middle Aged
Ophthalmoscopy
Organ Size
Photochemotherapy
Polyps--diagnosis
Ranibizumab
Recurrence
Retrospective Studies
Tomography, Optical Coherence